[Federal Register Volume 61, Number 67 (Friday, April 5, 1996)]
[Notices]
[Pages 15316-15317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-8491]



=======================================================================
-----------------------------------------------------------------------

PRESIDENTIAL ADVISORY COMMITTEE ON GULF WAR VETERANS' ILLNESSES


Meeting

AGENCY: Presidential Advisory Committee on Gulf War Veterans' 
Illnesses.

ACTION: Notice of open meeting.

-----------------------------------------------------------------------

SUMMARY: Under the provisions of the Federal Advisory Committee Act, 
this notice is hereby given to announce an open meeting of the 
Presidential Advisory Committee on Gulf War Veterans' Illnesses.

DATES: May 1, 1996, 9:00 a.m.-4:45 p.m.; May 2, 1996, 9:00 a.m.-3:30 
p.m.

PLACE: Omni Shorham, 2500 Calvert Street, NW., Washington, DC 20008.

SUPPLEMENTARY INFORMATION: The President established the Presidential 
Advisory Committee on Gulf War Veterans' Illnesses by Executive Order 
12961, May 26, 1995. The purpose of this committee is to review and 
provide recommendations on the full range of government activities 
associated with Gulf War veterans' illnesses. The committee reports to 
the President through the Secretary of Defense, the Secretary of Health 
and Human Services, and the Secretary of Veterans Affairs. The 
committee members have expertise relevant to the functions of the 
committee and are appointed by the President from non-Federal sectors.

Tentative Agenda

Wednesday, May 1, 1996

9:00 a.m.  Call to order and opening remarks
9:05 a.m.  Public comment
10:15 a.m.  Break
10:30 a.m.  Report on research funded through the 1995 Broad Agency 
Announcement: Department of Defense (DOD)
11:00 a.m.  Followup on chemical and biological warfare (CBW) panel 
meeting
11:30 a.m.  Medical evaluation of possible CBW exposures in the Gulf 
War
12:15 p.m.  Lunch
1:30 p.m.  Detection of CBW agents during the Gulf War
3:00 p.m.  Break
3:30 p.m.  Effectiveness of U.S. CBW defense measures
4:45 p.m.  Meeting recessed

Thursday, May 2, 1996

9:00 a.m.  Call to order
9:05 a.m.  Health effects of low-level chemical warfare agent exposure
10:45 a.m.  Break
11:00 a.m.  Health effects of multiple vaccines
12:00 p.m.  Lunch
1:00 p.m.  Antidotes to CBW agents: DOD
2:00 p.m.  Antidotes to CBW agents: Food and Drug Administration
3:00 p.m.  Committee and staff discussion: Next Steps
3:30 p.m.  Meeting adjourned

    A final agenda will be available at the meeting.
    
[[Page 15317]]


Public Participation

    The meeting is open to the public. Members of the public who wish 
to make oral statements should contact the Advisory Committee at the 
address or telephone number listed below at least five business days 
prior to the meeting. Reasonable provisions will be made to include on 
the agenda presentations from individuals who have not yet had an 
opportunity to address the Advisory Committee. Priority will be given 
to Gulf War veterans and their families. The Advisory Committee Chair 
is empowered to conduct the meeting in a fashion that will facilitate 
the orderly conduct of business. People who wish to file written 
statements with the Advisory Committee may do so at any time.

FOR FURTHER INFORMATION CONTACT: John D. Longbrake, Presidential 
Advisory Committee on Gulf War Veterans' Illnesses, 1411 K Street NW., 
suite 1000, Washington, DC 20005, Telephone: (202) 761-0066, Fax: (202) 
761-0310.

    Dated: April 2, 1996.
C.A. Bock,
Federal Register Liaison Officer, Presidential Advisory Committee on 
Gulf War Veterans' Illnesses.
[FR Doc. 96-8491 Filed 4-4-96; 8:45 am]
BILLING CODE 3610-76-M